Zymeworks' Unattributed - IV Round

Zymeworks raised a round of funding on December 19, 2014. Investors include Fonds de Solidarite FTQ.

Zymeworks (NYSE: ZYME) (TSX: ZYME) is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of multifunctional biotherapeutics.…

Articles about Zymeworks' Unattributed - IV Round: